Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain
Clinical trial NCT03226574 · COMPLETED
Trial details
- NCT number
- NCT03226574
- Sponsor
- Sorrento Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2020-03-18
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.